Nader Shaikh: Clinical Trials

5 trials sponsored by Nader Shaikh, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 3 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 42Recruiting 2

Follow Nader Shaikh: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)
Amoxicillin, Amoxi Clavulanate, Amoxicillin Placebo - ACUTE SINUSITIS, Sinusitis
Phase 4RecruitingNader Shaikh11002026-10-012026-10-20
Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)
Amoxicillin, Amoxicillin-Clavulanate, Amoxicillin Placebo - Acute Otitis Media (AOM)
Phase 4RecruitingNader Shaikh11002026-10-012026-10-20
Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?
Amoxicillin-clavulanate, Placebo - Sinusitis, Respiratory Tract Infections
Phase 3CompletedNader Shaikh5152016-02-012023-06-29
Reduced Clavulanate Formulation of Amoxicillin-Clavulanate in Children 6-23 Months With Acute Otitis Media
Amoxicillin-Clavulanate potassium - Acute Otitis Media
Phase 3CompletedNader Shaikh1122015-12-012018-01-03
Corticosteroids for Children With Febrile Urinary Tract Infections
Placebo, Dexamethasone - Acute Urinary Tract Infection, Urinary Tract Infection
Phase 3CompletedNader Shaikh5462011-09-012019-07-02

Conditions studied

Otitis (2)  ·  Otitis Media (2)  ·  Sinusitis (2)  ·  Respiratory Tract Infections (1)  ·  Urinary Tract Infections (1)

Interventions

Amoxicillin-Potassium Clavulanate Combination (4)  ·  Amoxicillin (2)  ·  Adrenal Cortex Hormones (1)  ·  Dexamethasone (1)  ·  Methylprednisolone (1)

Countries

United States (5)

Top investigators

Ellen R Wald, MD (1)

Results publications

PMID 28438923, PMID 32556960, PMID 34251495, PMID 37490085

NIH funding

R01DK087870 (1), U01AI118506 (1)